Big Move For Cleveland BioLabs, Inc.
Fri, Jan 17, 2020 at 05:30 PM
Cleveland BioLabs, Inc. (CBLI:NASDAQ) rocketted at $1.07, representing a gain of 27.1%. On Thu 16 Jan 20, CBLI:NASDAQ touched a New 2-Week Intraday High of $1.05. From Thu 26 Dec 19, the stock recorded 57.14% Up Days and 46.67% Green Days
About Cleveland BioLabs, Inc. (CBLI:NASDAQ)
Cleveland BioLabs Inc is a biopharmaceutical company developing novel approaches to activate immune system & address medical needs. Its proprietary platform of toll-like immune receptor activators are used in radiation, oncology immunotherapy & vaccine.
Top 10 Gainers:
- iMedia Brands, Inc. (IMBI:NASDAQ), 42.22%
- CPI Card Group Inc. (PMTS:NASDAQ), 37.7%
- Platinum Group Metals Ltd. (PLG:NYSEMKT), 35.9%
- Titan Pharmaceuticals, Inc. (TTNP:NASDAQ), 33.6%
- Proteon Therapeutics, Inc. (PRTO:NASDAQ), 30.5%
- Seneca Biopharma, Inc. (SNCA:NASDAQ), 28%
- Aptinyx Inc. (APTX:NASDAQ), 27.78%
- Cleveland BioLabs, Inc. (CBLI:NASDAQ), 27.08%
- Kirkland's, Inc. (KIRK:NASDAQ), 25.98%
- Stage Stores, Inc. (SSI:NYSE), 21.99%